Cellular catabolism of recombinant tissue-type plasminogen activator. Identification and characterization of a novel high affinity uptake system on rat hepatocytes
- PMID: 2439503
Cellular catabolism of recombinant tissue-type plasminogen activator. Identification and characterization of a novel high affinity uptake system on rat hepatocytes
Abstract
The uptake, internalization, and intracellular degradation of 125I-labeled recombinant tissue-type plasminogen activator (rt-PA) by isolated rat hepatocytes was investigated. Incubation at 37 degrees C resulted in internalization of 125I-rt-PA, followed by the appearance of labeled trichloroacetic acid-soluble material in the incubation media due to degradation of rt-PA. Degradation of rt-PA was inhibited by the presence of NH4Cl (10 mM) or chloroquine (1 mM) (lysosomal tropic agents) in the incubation media. This suggests that rt-PA degradation occurs intracellularly, perhaps within the lysosomes. 125I-rt-PA was taken up by rat hepatocytes through a specific, high affinity mechanism with half-maximal uptake at 10 nM. Uptake of 125I-rt-PA was not inhibited by glycopeptides isolated from rt-PA nor by several other glycoproteins known to be cleared by identified hepatic receptors. These results suggest that the uptake of rt-PA by rat hepatocytes involves a receptor specific for t-PA and is not mediated by a carbohydrate-specific receptor.
Similar articles
-
Internalization of recombinant tissue-type plasminogen activator by isolated rat hepatocytes is via coated pits.Thromb Haemost. 1990 Apr 12;63(2):251-8. Thromb Haemost. 1990. PMID: 1973006
-
Effects of lysosomal inhibitors on 125I-insulin and 125I-asialofetuin degradation by the isolated, perfused rat liver and isolated rat hepatocytes.Diabetes. 1985 May;34(5):446-51. doi: 10.2337/diab.34.5.446. Diabetes. 1985. PMID: 2580748
-
Endocytosis and lysosomal delivery of tissue plasminogen activator-inhibitor 1 complexes in Hep G2 cells.Blood. 1992 Dec 1;80(11):2746-54. Blood. 1992. PMID: 1333299
-
Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells.Thromb Res Suppl. 1990;10:63-71. doi: 10.1016/0049-3848(90)90379-q. Thromb Res Suppl. 1990. PMID: 2107599 Review.
-
Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activator.Arzneimittelforschung. 1991 Dec;41(12):1310-9. Arzneimittelforschung. 1991. PMID: 1815534 Review.
Cited by
-
Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells.Biochem J. 1992 Aug 1;285 ( Pt 3)(Pt 3):799-804. doi: 10.1042/bj2850799. Biochem J. 1992. PMID: 1323274 Free PMC article.
-
alpha-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells.J Clin Invest. 1994 Feb;93(2):703-10. doi: 10.1172/JCI117023. J Clin Invest. 1994. PMID: 8113404 Free PMC article.
-
Development and Testing of Thrombolytics in Stroke.J Stroke. 2021 Jan;23(1):12-36. doi: 10.5853/jos.2020.03349. Epub 2021 Jan 31. J Stroke. 2021. PMID: 33600700 Free PMC article. Review.
-
Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.Drugs. 1989 Sep;38(3):346-88. doi: 10.2165/00003495-198938030-00003. Drugs. 1989. PMID: 2509190 Review.
-
Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator.Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7427-31. doi: 10.1073/pnas.89.16.7427. Proc Natl Acad Sci U S A. 1992. PMID: 1502154 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources